High Falls Advisors, Inc Amgen Inc Transaction History

High Falls Advisors, Inc

$425 Million
Q3 2024

A detailed history of High Falls Advisors, Inc transactions in Amgen Inc stock. As of the latest transaction made, High Falls Advisors, Inc holds 1,496 shares of AMGN stock, worth $394,016. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,496

Previous 1,490 0.4%

Holding current value

$394,016

Previous $465,000 3.66%

% of portfolio

0.11%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $1,856 - $2,024	6 Added 0.4%	1,496 $482,000
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $26,275 - $31,931	100 Added 7.19%	1,490 $465,000
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $51,140 - $57,691	-200 Reduced 12.58%	1,390 $400,000
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $21,865 - $27,145	100 Added 6.71%	1,590 $427,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $171,772 - $218,257	-750 Reduced 33.48%	1,490 $391,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $69,213 - $77,022	-300 Reduced 11.81%	2,240 $545,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1,096 - $1,212	-5 Reduced 0.2%	2,540 $614,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $8,750 - $10,014	-44 Reduced 1.7%	2,545 $572,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.04%	2,589 $551,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $221 - $258	1 Added 0.04%	2,588 $644,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $559,775 - $666,592	2,587 New	2,587 $594,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $690,105 - $767,453	-2,941 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $197 - $242	1 Added 0.03%	2,941 $694,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $182 - $241	1 Added 0.03%	2,940 $596,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $189 - $243	1 Added 0.03%	2,939 $708,000
Q3 2019 Nov 21, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.03%	2,938 $568,000
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $4,167 - $4,885	-25 Reduced 0.84%	2,937 $541,000
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $5,064 - $5,708	28 Added 0.95%	2,962 $563,000
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $15,342 - $17,909	-86 Reduced 2.85%	2,934 $571,000
Q3 2018 Nov 16, 2018	SELL	$185.29 - $208.89 $159,719 - $180,063	-862 Reduced 22.21%	3,020 $626,000
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $42,508 - $47,746	-256 Reduced 6.19%	3,882 $717,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $7,963 - $9,306	-47 Reduced 1.12%	4,138 $705,000
Q4 2017 Feb 16, 2018	SELL	$168.79 - $188.59 $39,328 - $43,941	-233 Reduced 5.27%	4,185 $728,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $739,087 - $843,838	4,418	4,418 $824,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on High Falls Advisors, Inc with notifications on news.

Account

High Falls Advisors, Inc Amgen Inc Transaction History